Medical Weight Loss for New Orleans, Louisiana Residents

New Orleans, Louisiana residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving New Orleans through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Serving New Orleans, Louisiana by telehealth: your consultation, prescription, and follow-ups all happen by secure video, with compounded medication shipped to your door. Our only physical clinic is in Costa Mesa, California; everything else is virtual. Doctor review just $119 (medication separate).

Why New Orleans Residents Choose New Hope Weight Loss

Continuity is the quiet advantage New Orleans patients notice most. Because Dr. Anjmun Sharma oversees your case throughout, the person adjusting your dose in month three is the same physician who reviewed you in week one. Nothing gets lost in a handoff. That consistency, delivered by telehealth from our Costa Mesa clinic, is what turns a prescription into actual ongoing care for people all over Louisiana.

New Orleans is served through telehealth from our Costa Mesa, California clinic. The physician consultation, prescription, and follow-up all happen by secure video.

From the first visit to your refills, people in New Orleans, Louisiana are cared for by Dr. Sharma through telehealth, so the only thing missing is the commute to Costa Mesa. We care for patients throughout the French Quarter, the Garden District, Uptown, Mid-City, Marigny, and Greater New Orleans. Follow-up check-ins are handled remotely, so adjusting your dose is simple whether you live near downtown New Orleans or out toward the French Quarter, the Garden District, Uptown, Mid-City, Marigny, and Greater New Orleans.

Most people across New Orleans do not wait for an opening, they pick a time, meet Dr. Sharma by video, and can begin treatment within days. For patients across New Orleans, compounded semaglutide starts at $166 per month, with a 90-day program available for $499, and the medication cost is kept separate from the $119 physician review. From one end of Louisiana to the other, New Hope Weight Loss provides physician-supervised GLP-1 care by telehealth from our Costa Mesa, California clinic, with no need to visit in person.

GLP-1 Weight Loss Programs Available

Which GLP-1 program is right for you?

Our 90-Day Metabolic Reset runs on semaglutide, the same active ingredient as Wegovy and Ozempic. It starts at $166 a month, or $499 for 90 days, and branded-drug trials reported average loss near 15 to 17 percent. Because compounded semaglutide is not FDA-approved or brand-identical, results vary. Dr. Sharma guides every New Orleans patient by telehealth.

And if you want more horsepower

Tirzepatide, from $233 a month, adds GIP to the usual GLP-1 action. In branded-drug trials, dose-qualified participants reached up to 22.5 percent loss, which is not the typical outcome. It shares its active ingredient with Mounjaro and Zepbound.

A $119 physician review starts the process. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for New Orleans

The path from curious to treated is short, and it all runs through your screen. People in New Orleans start by completing a health-and-weight intake quiz online. Dr. Anjmun Sharma reviews every answer and meets you over secure video, usually within 48 hours, to talk through whether a compounded GLP-1 like semaglutide or tirzepatide fits your goals and history. When she prescribes, a state-licensed 503(a) pharmacy ships the medication to your New Orleans home in cold-pack packaging designed to keep it stable. After that, you and Dr. Sharma stay connected through video follow-ups, so your progress is supported from any corner of .

Frequently Asked Questions, New Orleans

How does someone in New Orleans access New Hope Weight Loss?

Access from New Orleans is entirely online. Our one physical clinic stands in Costa Mesa, California, while we serve New Orleans, Louisiana through telehealth. To begin, Dr. Anjmun Sharma meets you over secure video, reviews your background, and confirms whether you are eligible for a compounded GLP-1 program.

Is a clinic visit part of the process for New Orleans residents?

A clinic visit is never part of it for New Orleans. The model is fully telehealth, so your consult, refills, and check-ins happen from home. After Dr. Sharma approves you, medication is shipped to New Orleans inside cold-pack packaging designed to maintain a steady temperature during transit.

What are the fees for New Orleans patients?

The physician review costs $119. Compounded semaglutide runs from $166 each month, or $499 for the 90-day program, and tirzepatide from $233 each month. Medication is billed on its own. We honor HSA, FSA, Klarna, and Affirm, and New Orleans residents are charged no distance surcharge.

What areas of New Orleans do you serve?

We serve patients from across New Orleans by telehealth, including the French Quarter, the Garden District, Uptown, Mid-City, Marigny, and Greater New Orleans.

How quickly can a New Orleans patient get started?

Most patients complete the 2-minute quiz and intake form the same day. Dr. Sharma typically reviews within 48 hours, and if you are a candidate and telehealth-eligible, the prescription goes to the 503(a) pharmacy for shipping to New Orleans.

New Orleans Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving New Orleans, Louisiana by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.